Currently Viewing:
Newsroom
Currently Reading
Chemoimmunotherapy Assures Better Outcomes in Ovarian Cancer
June 15, 2016 – Surabhi Dangi-Garimella, PhD
A Smarter Screening Strategy for Prostate Cancer Can Predict Mortality
June 14, 2016 – Surabhi Dangi-Garimella, PhD
Adjuvant Chemotherapy Can Improve Survival in Early Stage NSCLC
June 14, 2016 – Surabhi Dangi-Garimella, PhD
Medication-Assisted Opioid Treatment Severely Underused, Study Finds
June 14, 2016 – Cate Douglass
What We're Reading: CMS May Require Medicare Hospitals Follow New Antibiotic Controls
June 14, 2016 – AJMC Staff
What We're Reading: WHO Recommends Delaying Pregnancy in Zika-Infected Areas
June 13, 2016 – AJMC Staff
Survey Finds Family Physicians Divided on Recommending LDCT Screening
June 13, 2016 – Surabhi Dangi-Garimella, PhD
Vitamin D Reduces Hyperglycemia Risk Associated With Atypical Antipsychotics
June 12, 2016 – Jessica Men
Flu Shot Associated With Extra Benefits in Patients With Heart Failure
June 11, 2016 – Jackie Syrop

Chemoimmunotherapy Assures Better Outcomes in Ovarian Cancer

Surabhi Dangi-Garimella, PhD
According to research published in the journal Clinical Cancer Research, immunotherapy right after chemotherapy can piggy back on the immune modifications caused by the chemotherapy, to improve response to treatment in ovarian cancer.
According to research published in the journal Clinical Cancer Research, immunotherapy right after chemotherapy can piggy back on the immune modifications caused by the chemotherapy, to improve patient response to treatment.

The study assessed the effect of neoadjuvant chemotherapy (NACT) on immune activation in advanced stage, high-grade serous carcinomas. Blood and tissue samples, from 54 patients undergoing platinum-based NACT prior to surgery and 6 undergoing surgery without chemotherapy, were obtained pre and posttreatment. The samples were analyzed for T-cell density and phenotype, and for markers of inflammation by immunohistochemistry and RNA sequencing. Patients were classified as good and poor responders based on a chemotherapy response score that correlates with progression-free survival and overall survival.

Analysis of the tissue samples discovered T-cell activation in samples after NACT, and the activation had a significant correlation with a good response to NACT. Biopsy samples that showed a good response to chemotherapy also had fewer T regulatory cells. Additionally, the authors report that the plasma levels of proinflammatory cytokines decreased in all patients after NACT; also a high proportion of T cells in biopsies expressed immune checkpoint molecules programmed death 1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), and programmed death ligand 1 (PD-L1) levels were significantly increased after NACT.

“Although we found that chemotherapy activated the T cells, the levels of the protein PD-L1 remained the same or increased. However, immune checkpoint blockade therapies can stop this from happening, so we suggest that immune checkpoint blockade might be a suitable form of immunotherapy to give to ovarian cancer patients after chemotherapy,” said Frances R. Balkwill, PhD, senior author of the study, in a statement. Balkwill is professor of cancer biology at Barts Cancer Institute in Queen Mary University of London, United Kingdom.

“The chemotherapies, carboplatin and paclitaxel, given in our study are also used to treat many different cancer types. It will, therefore, be very interesting and potentially promising if similar effects are seen in other cancer types, such as lung cancer,” Balkwill added.

Reference

Böhm S, Montfort A, Pearce O, et al. Neoadjuvant chemotherapy modulates the immune microenvironment in metastases of tubo-ovarian high-grade serous carcinoma. Clin Cancer Res. 2016;22;3025. doi:10.1158/1078-0432.CCR-15-2657.

 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up